Related Experiment Videos
Advances in Kawasaki disease
Stanford T Shulman1, Anne H Rowley
1Division of Infectious Diseases, Children's Memorial Hospital, Feinberg School of Medicine, Northwestern University, 2300 Children's Plaza, Box 20, Chicago, IL 60614, USA. sshulman@northwestern.edu
European Journal of Pediatrics
|September 7, 2004
Summary
Researchers are uncovering the causes of Kawasaki disease (KD), revealing an immune response suggesting an intracellular pathogen. While effective treatments exist, identifying the exact cause is key for better diagnostics and prevention.
Area of Science:
- Immunology
- Pediatric Cardiology
- Infectious Disease
Background:
- Kawasaki disease (KD) is a critical childhood illness affecting coronary arteries.
- Inflammatory infiltrates in KD suggest an immune response to an intracellular pathogen entering through mucosa.
- Recent research deepens the understanding of KD's complex etiopathogenesis.
Purpose of the Study:
- To explore the immune mechanisms underlying Kawasaki disease.
- To identify potential etiologic agents and diagnostic markers for KD.
- To discuss the implications for clinical diagnosis and therapeutic strategies.
Main Methods:
- Analysis of inflammatory infiltrates in KD coronary artery aneurysms, including CD8 T lymphocytes, macrophages, and IgA plasma cells.
- Investigation of oligoclonal IgA response within the vascular wall.
- Detection of a KD-associated antigen using synthetic antibodies derived from KD oligoclonal IgA.
Main Results:
- The inflammatory profile points to an immune response against an intracellular pathogen.
- An oligoclonal IgA response and a specific KD antigen have been identified in affected tissues.
- These findings offer novel avenues for identifying the disease's causative agent.
Conclusions:
- Identifying the etiologic agent of KD is crucial for developing specific diagnostic tests.
- Further research into KD's pathogenesis is essential for advancing targeted therapies and prevention strategies.
- Addressing incomplete KD cases remains a significant clinical challenge.